Your session is about to expire
← Back to Search
Study Summary
This trial is to see if Zofin is safe and effective in people with long-term COVID-19 symptoms.
- COVID-19
- Coronavirus
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have been feeling tired for more than six weeks after being diagnosed with COVID-19, even though you no longer have the virus.People who have severe depression with a score of 15 or higher on a depression scale will not be included.You had COVID-19 in the past and still feel very tired more than 6 weeks after testing negative for the virus.Anyone can participate regardless of gender.You have certain health conditions that make you ineligible for the study. These include: liver, kidney or heart disease, low blood pressure, abnormal heart rhythms, low oxygen levels, bleeding disorders, active infections, drug abuse or dependence, uncontrolled migraines or neuropathy, and certain types of cancer. You are also ineligible if you are pregnant, nursing, have a BMI over 42, or have had an organ transplant.You have a score of 4 or more on the Chalder Fatigue Scale.You have a positive test for SARS-CoV-2.You have not fully recovered from COVID-19 for at least over 6 weeks.You have been experiencing extreme fatigue, body aches, and joint pain for at least 6 weeks, which interferes with your daily activities. You did not have these symptoms before getting COVID-19. You will be asked to complete some questionnaires to assess the severity of your symptoms. You also need to have access to medical documentation of previous COVID-19 treatments and be willing to participate in multiple follow-up visits. You must be able to understand and sign a consent form, and have adequate venous access.You cannot have thoughts of hurting yourself or others.You recently had COVID-19, but now you are experiencing severe tiredness, body aches, or joint pain that are not related to COVID-19.
- Group 1: Group 1: Zofin
- Group 2: Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this experiment in progress and accepting new participants?
"According to clinicaltrials.gov, the recruitment phase of this medical trial is underway. This study went live on April 14th 2022 and was last modified in November 14th 2022."
How many participants has this trial enrolled to date?
"Yes, clinicaltrials.gov confirms that this medical trial is presently recruiting patients and has been since April 14th 2022 (last updated November 14th 2022). The study seeks to enroll 30 participants from 4 different sites."
How widely is this investigation taking place?
"There are 4 participating sites for this research, these include Assuta Family Medical Group in North Hollywood, NewportNativeMD in Newport Beach and United Memorial Medical Centerin Houston amongst others."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger